• XenoPort Sinks as Spasticity Drug For MS Fails in Trial
  • Merck Insomnia Drug Safer at Lower Dose, FDA Staff Says
  • Elan Makes Two Acquisitions for $380 Million
  • China’s Stocks Rise to Seven-Week High as Trading Volumes Surge
  • Japan Biotech Firms Jump as Abenomics Cash Spurs Speculation
  • Lundbeck-Takeda Drug Fights Depression Better at Higher Dose
  • SAC Says Cooperation With U.S. No Longer ‘Unconditional’
  • Credit Swaps in U.S. Fall as Leading Indicators, Sentiment Rise
  • Puma Biotech Gains After Rival Drug Data Show No Threat
  • J&J Will Stop Sales of Metal-on-Metal Hip Replacements
  • Sanofi, French Government at Odds Over Fate of Research Site
  • Expected Earnings Growth for Industries in Stoxx 600
  • Petrobras, Merck Lead $54 Billion of Company Bond Sales in U.S.
  • Merck KGaA Doesn’t Rule Out Pursuing Lung-Cancer Vaccine
  • Lilly, ThyssenKrupp, Adidas, AMD: Intellectual Property
« Previous 1 2 3 4 5 6 Next »